Using Clinical Trial Data to Estimate the Costs of Behavioral Interventions for Potential Adopters: A Guide for Trialists.
behavioral intervention
clinical trial
costing
medication adherence
outcomes research
pragmatic trial
preventive services
translating research into practice
Journal
Medical decision making : an international journal of the Society for Medical Decision Making
ISSN: 1552-681X
Titre abrégé: Med Decis Making
Pays: United States
ID NLM: 8109073
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
pubmed:
22
11
2020
medline:
13
8
2021
entrez:
21
11
2020
Statut:
ppublish
Résumé
Behavioral interventions involving electronic devices, financial incentives, gamification, and specially trained staff to encourage healthy behaviors are becoming increasingly prevalent and important in health innovation and improvement efforts. Although considerations of cost are key to their wider adoption, cost information is lacking because the resources required cannot be costed using standard administrative billing data. Pragmatic clinical trials that test behavioral interventions are potentially the best and often only source of cost information but rarely incorporate costing studies. This article provides a guide for researchers to help them collect and analyze, during the trial and with little additional effort, the information needed to inform potential adopters of the costs of adopting a behavioral intervention. A key challenge in using trial data is the separation of implementation costs, the costs an adopter would incur, from research costs. Based on experience with 3 randomized clinical trials of behavioral interventions, this article explains how to frame the costing problem, including how to think about costs associated with the control group, and describes methods for collecting data on individual costs: specifications for costing a technology platform that supports the specialized functions required, how to set up a time log to collect data on the time staff spend on implementation, and issues in getting data on device, overhead, and financial incentive costs.
Identifiants
pubmed: 33218296
doi: 10.1177/0272989X20973160
pmc: PMC7772275
mid: NIHMS1640567
doi:
Banques de données
ClinicalTrials.gov
['NCT02708654', 'NCT01798784', 'NCT02246959']
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
9-20Subventions
Organisme : NIA NIH HHS
ID : R01 AG043844
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL118195
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL128465
Pays : United States
Références
Clin Trials. 2019 Aug;16(4):399-409
pubmed: 31148473
JAMA. 2016 Sep 13;316(10):1093-103
pubmed: 27623463
AIDS Behav. 2010 Dec;14(6):1340-6
pubmed: 20809380
Cochrane Database Syst Rev. 2016 Dec 21;12:CD004371
pubmed: 28000212
Circ Cardiovasc Qual Outcomes. 2019 Apr;12(4):e005126
pubmed: 30939922
Am J Manag Care. 2016 Apr 01;22(4):e141-6
pubmed: 27143350
Cochrane Database Syst Rev. 2019 Jul 17;7:CD004307
pubmed: 31313293
JAMA. 2019 Apr 16;321(15):1451-1452
pubmed: 30907936